Symrise AG (OTCMKTS:SYIEY - Get Free Report) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 25,500 shares, a growth of 207.2% from the April 30th total of 8,300 shares. Currently, 0.0% of the company's shares are sold short. Based on an average daily volume of 105,600 shares, the days-to-cover ratio is currently 0.2 days.
Symrise Trading Up 1.0%
SYIEY traded up $0.30 on Monday, hitting $29.80. The company had a trading volume of 429,719 shares, compared to its average volume of 98,837. The company's fifty day moving average price is $27.65 and its 200 day moving average price is $26.61. The company has a quick ratio of 1.64, a current ratio of 2.97 and a debt-to-equity ratio of 0.61. Symrise has a 1-year low of $23.96 and a 1-year high of $34.58.
Symrise Cuts Dividend
The firm also recently disclosed a dividend, which will be paid on Monday, June 9th. Stockholders of record on Friday, May 23rd will be paid a $0.1762 dividend. The ex-dividend date is Thursday, May 22nd. This represents a dividend yield of 0.6%.
Wall Street Analysts Forecast Growth
Separately, Citigroup raised Symrise from a "hold" rating to a "strong-buy" rating in a research note on Monday, April 14th.
View Our Latest Report on Symrise
Symrise Company Profile
(
Get Free Report)
Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. It operates through two segments, Taste, Nutrition & Health; and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and product solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for fish feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.
Featured Articles
Before you consider Symrise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Symrise wasn't on the list.
While Symrise currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.